Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Managing ambulatory ulcerative colitis patients with infliximab: A long-term follow-up study in primary gastroenterology centers.

Tursi A, Elisei W, Picchio M, Penna A, Lecca PG, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G.

Eur J Intern Med. 2014 Jul 30. pii: S0953-6205(14)00207-6. doi: 10.1016/j.ejim.2014.07.007. [Epub ahead of print]

PMID:
25086677
[PubMed - as supplied by publisher]
2.

Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres.

Tursi A, Elisei W, Picchio M, Penna A, Lecca PG, Forti G, Giorgetti G, Faggiani R, Zampaletta C, Pelecca G, Brandimarte G.

Eur J Intern Med. 2014 Jun;25(5):485-90. doi: 10.1016/j.ejim.2014.02.010. Epub 2014 Mar 13.

PMID:
24631020
[PubMed - in process]
3.

Methods of biological network inference for reverse engineering cancer chemoresistance mechanisms.

Lecca P.

Drug Discov Today. 2014 Feb;19(2):151-63. doi: 10.1016/j.drudis.2013.10.026. Epub 2013 Nov 5.

PMID:
24211413
[PubMed - in process]
4.

Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.

Tursi A, Elisei W, Giorgetti GM, Inchingolo CD, Nenna R, Picchio M, Maiorano M, Penna A, Lecca PG, Brandimarte G.

Eur Rev Med Pharmacol Sci. 2013 Feb;17(3):342-8.

PMID:
23426537
[PubMed - indexed for MEDLINE]
Free Article
5.

An integrative network inference approach to predict mechanisms of cancer chemoresistance.

Lecca P.

Integr Biol (Camb). 2013 Mar;5(3):458-73. doi: 10.1039/c2ib20205k.

PMID:
23340828
[PubMed - indexed for MEDLINE]
6.

Parameter sensitivity analysis of stochastic models: application to catalytic reaction networks.

Damiani C, Filisetti A, Graudenzi A, Lecca P.

Comput Biol Chem. 2013 Feb;42:5-17. doi: 10.1016/j.compbiolchem.2012.10.007. Epub 2012 Nov 7.

PMID:
23246776
[PubMed - indexed for MEDLINE]
7.

Algorithmic modeling quantifies the complementary contribution of metabolic inhibitions to gemcitabine efficacy.

Kahramanońüullari O, Fantaccini G, Lecca P, Morpurgo D, Priami C.

PLoS One. 2012;7(12):e50176. doi: 10.1371/journal.pone.0050176. Epub 2012 Dec 11.

PMID:
23239976
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Biological network inference for drug discovery.

Lecca P, Priami C.

Drug Discov Today. 2013 Mar;18(5-6):256-64. doi: 10.1016/j.drudis.2012.11.001. Epub 2012 Nov 10. Review.

PMID:
23147668
[PubMed - indexed for MEDLINE]
9.

Modelling non-homogeneous stochastic reaction-diffusion systems: the case study of gemcitabine-treated non-small cell lung cancer growth.

Lecca P, Morpurgo D.

BMC Bioinformatics. 2012;13 Suppl 14:S14. doi: 10.1186/1471-2105-13-S14-S14. Epub 2012 Sep 7.

PMID:
23095709
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Inferring biochemical reaction pathways: the case of the gemcitabine pharmacokinetics.

Lecca P, Morpurgo D, Fantaccini G, Casagrande A, Priami C.

BMC Syst Biol. 2012 May 28;6:51. doi: 10.1186/1752-0509-6-51.

PMID:
22640931
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Network inference from time-dependent Omics data.

Lecca P, Nguyen TP, Priami C, Quaglia P.

Methods Mol Biol. 2011;719:435-55. doi: 10.1007/978-1-61779-027-0_20. Review.

PMID:
21370096
[PubMed - indexed for MEDLINE]
12.

Stochastic simulation of the spatio-temporal dynamics of reaction-diffusion systems: the case for the bicoid gradient.

Lecca P, Ihekwaba AE, Dematté L, Priami C.

J Integr Bioinform. 2010 Nov 23;7(1):150. doi: 10.2390/biecoll-jib-2010-150.

PMID:
21098882
[PubMed - indexed for MEDLINE]
13.

Prevalence of celiac disease and symptoms in relatives of patients with celiac disease.

Tursi A, Elisei W, Giorgetti GM, Gaspardone A, Lecca PG, Di Cesare L, Brandimarte G.

Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):567-72.

PMID:
20712266
[PubMed - indexed for MEDLINE]
14.

Calibration of dynamic models of biological systems with KInfer.

Lecca P, Palmisano A, Ihekwaba A, Priami C.

Eur Biophys J. 2010 May;39(6):1019-39. doi: 10.1007/s00249-009-0520-3. Epub 2009 Aug 11.

PMID:
19669750
[PubMed - indexed for MEDLINE]
15.

The endoscopic spectrum of segmental colitis associated with diverticulosis.

Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Lecca PG, Di Cesare L, Inchingolo CD, Aiello F.

Colorectal Dis. 2010 May;12(5):464-70. doi: 10.1111/j.1463-1318.2009.01969.x. Epub 2009 Jun 25.

PMID:
19558591
[PubMed - indexed for MEDLINE]
16.

Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.

Larghi A, Verna EC, Lecca PG, Costamagna G.

Clin Cancer Res. 2009 Mar 15;15(6):1907-14. doi: 10.1158/1078-0432.CCR-08-1966. Epub 2009 Mar 10. Review.

PMID:
19276278
[PubMed - indexed for MEDLINE]
Free Article
17.

Concomitant intraductal papillary mucinous neoplasm and pancreatic endocrine tumour: Report of two cases and review of the literature.

Larghi A, Stobinski M, Galasso D, Lecca PG, Costamagna G.

Dig Liver Dis. 2009 Oct;41(10):759-61. doi: 10.1016/j.dld.2009.01.005. Epub 2009 Feb 14.

PMID:
19223252
[PubMed - indexed for MEDLINE]
18.

Evaluation of hilar biliary strictures by using a newly developed forward-viewing therapeutic echoendoscope: preliminary results of an ongoing experience.

Larghi A, Lecca PG, Ardito F, Rossi ED, Fadda G, Nuzzo G, Costamagna G.

Gastrointest Endosc. 2009 Feb;69(2):356-60. doi: 10.1016/j.gie.2008.08.038.

PMID:
19185697
[PubMed - indexed for MEDLINE]
19.
20.

EUS-directed transpapillary self-expandable metallic stent placement after successful interventional EUS-guided cholangiography.

Larghi A, Lecca PG, Mutignani M, Costamagna G.

Gastrointest Endosc. 2008 May;67(6):996-8. doi: 10.1016/j.gie.2007.10.004. Epub 2008 Feb 4. No abstract available.

PMID:
18249404
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk